Novitas Issues Final Local Coverage Determination for the 4Kscore® Test
November 15, 2019 08:00 ET
|
OPKO Health, Inc.
MIAMI, Nov. 15, 2019 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (OPK) today announced that Novitas Solutions, Inc. has issued its final Local Coverage Determination (LCD) for Medicare payments for the...
OPKO Health Reports 2019 Third Quarter Business Highlights and Financial Results
November 05, 2019 16:05 ET
|
OPKO Health, Inc.
MIAMI, Nov. 05, 2019 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) reports business highlights and financial results for the three months ended September 30, 2019. Business Highlights ...
OPKO Health to Report Third Quarter 2019 Financial Results on November 5, 2019
November 01, 2019 08:00 ET
|
OPKO Health, Inc.
MIAMI, Nov. 01, 2019 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to report its operating and financial results for the three months ended September 30, 2019, as well as provide...
OPKO Health, Inc. Announces Pricing of its Offering of Common Stock
October 24, 2019 18:57 ET
|
OPKO Health, Inc.
MIAMI, Oct. 24, 2019 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (“OPKO Health” or the “Company”) (NASDAQ:OPK) today announced the pricing of an underwritten public offering of 50 million shares of its...
OPKO Health, Inc. Announces Proposed Offering of Common Stock
October 22, 2019 16:05 ET
|
OPKO Health, Inc.
MIAMI, Oct. 22, 2019 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (“OPKO Health” or the “Company”) (NASDAQ:OPK) today announced that, subject to market and other conditions, it intends to offer and sell up...
OPKO and Pfizer Announce Positive Phase 3 Top-Line Results for Somatrogon, an Investigational Long-Acting Human Growth Hormone to Treat Children with Growth Hormone Deficiency
October 21, 2019 08:00 ET
|
OPKO Health, Inc.
— Results demonstrated potential to reduce current dosing frequency from once-daily to a single weekly injection — MIAMI and NEW YORK, Oct. 21, 2019 (GLOBE NEWSWIRE) -- OPKO Health Inc. (NASDAQ:...
OPKO Completes Pivotal Phase 3 Study for Somatrogon (hGH-CTP), an Investigational Long-Acting Growth Hormone Being Studied for the Treatment of Children With Growth Hormone Deficiency
August 29, 2019 09:24 ET
|
OPKO Health, Inc.
MIAMI, Aug. 29, 2019 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) today announced that the last patient has completed the final visit in the Company’s pivotal Phase 3 study evaluating the...
OPKO Health Reports 2019 Second Quarter Business Highlights and Financial Results
August 07, 2019 16:05 ET
|
OPKO Health, Inc.
MIAMI, Aug. 07, 2019 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) reports business highlights and financial results for the three months ended June 30, 2019. Business Highlights RAYALDEE...
OPKO Health to Report Second Quarter 2019 Financial Results on August 7, 2019
August 01, 2019 08:00 ET
|
OPKO Health, Inc.
MIAMI, Aug. 01, 2019 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to report its operating and financial results for the three months ended June 30, 2019, as well as provide guidance on...
OPKO Health’s BioReference Laboratories Forms a Strategic Collaboration With SOMOS to Improve Health Outcomes of Underserved New Yorkers
July 01, 2019 09:29 ET
|
OPKO Health, Inc.
SOMOS, New York City’s Largest Multi-Cultural Physician-Led Network, Selects BioReference as Preferred Provider for Diagnostic Testing BioReference to also assist with Patient-Centered Data...